REFERENCES
- Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation, and
treatment of coronavirus. [Updated 2020 Oct 4]. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing; January
2020.
- Ministry of National Health Services Regulations and Coordination.
COVID-19 health advisory platform. 2020. http://covid.gov.pk/.
Accessed 26 December, 2020.
- Singh A, Majumdar S, Singh R, Misra A. Role of corticosteroid in the
management of COVID-19: a systemic review and a clinician’s
perspective. Diabetes & Metabolic Syndrome: Clinical Research &
Reviews. 2020;14(5):971-978. doi:10.1016/j.dsx.2020.06.054
- Tobaiqy M, Qashqary M, Al-Dahery S et al. Therapeutic management of
patients with COVID-19: a systematic review. Infection Prevention in
Practice. 2020;2(3):100061. doi:10.1016/j.infpip.2020.100061
- Isidori A, Arnaldi G, Boscaro M et al. COVID-19 infection and
glucocorticoids: update from the Italian Society of Endocrinology
expert opinion on steroid replacement in adrenal insufficiency. J
Endocrinol Invest. 2020;43(8):1141-1147.
doi:10.1007/s40618-020-01266-w
- Stockman L, Bellamy R, Garner P. SARS: systematic review of treatment
effects. PLoS Med. 2006;3(9):e343. doi:10.1371/journal.pmed.0030343
- Arabi Y, Mandourah Y, Al-Hameed F et al. Corticosteroid therapy for
critically ill patients with Middle East respiratory syndrome. Am J
Respir Crit Care Med. 2018;197(6):757-767.
doi:10.1164/rccm.201706-1172oc
- Horby P, Lim W, Emberson J et al. Effect of dexamethasone in
hospitalized patients with COVID-19: preliminary report. 2020.
doi:10.1101/2020.06.22.20137273 [Preprint]
- Li H, Chen C, Hu F, et al. Impact of corticosteroid therapy on
outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection:
a systematic review and meta-analysis. Leukemia. 2020;34(6):1503-1511.
doi:10.1038/s41375-020-0848-3